Literature DB >> 9308759

The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices.

A D Blann1, C Steele, C N McCollum.   

Abstract

Nicotine is helpful in stopping smoking but its influence on cardiovascular risk factors is incomplete. Our aim was to determine its effect on blood pressure, routine haematology indices, and coagulation indices relevant to thrombosis. Eighteen subjects were seen whilst smoking (cotinine levels 1119 +/- 414 ng/ml), again after stopping smoking but while using nicotine chewing gum and/or skin patches (392 +/- 198 ng/ml), and again when not using nicotine (cotinine undetectable). There were no significant changes in blood pressures, platelet count, mean platelet volume, viscosity or anti-thrombin III. However, white blood cell count (p = 0.003), lymphocyte count (p = 0.016), red blood cell count (p = 0.02), haemoglobin (p <0.001), fibrinogen (p <0.001) and von Willebrand factor (p = 0.001) all fell between the first and second samples (when still using nicotine) but not between the second and third samples (when off nicotine). Oral and/or transdermal nicotine does not influence blood pressure or the haematology and coagulation indices we have measured.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9308759

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease.

Authors:  Robyn T Cohen; Michael R DeBaun; Morey A Blinder; Robert C Strunk; Joshua J Field
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

Review 2.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

Review 3.  Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors:  Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

4.  Multiplexed Isobaric Tag-Based Profiling of Seven Murine Tissues Following In Vivo Nicotine Treatment Using a Minimalistic Proteomics Strategy.

Authors:  Joao A Paulo; Mark P Jedrychowski; Edward T Chouchani; Lawrence Kazak; Steven P Gygi
Journal:  Proteomics       Date:  2018-05-02       Impact factor: 3.984

5.  Nicotine Mediates CD161a+ Renal Macrophage Infiltration and Premature Hypertension in the Spontaneously Hypertensive Rat.

Authors:  Sailesh C Harwani; Jason Ratcliff; Fayyaz S Sutterwala; Zuhair K Ballas; David K Meyerholz; Mark W Chapleau; Francois M Abboud
Journal:  Circ Res       Date:  2016-09-22       Impact factor: 17.367

6.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

Review 7.  Cardiovascular effects of pharmacologic therapies for smoking cessation.

Authors:  Diana M Sobieraj; William B White; William L Baker
Journal:  J Am Soc Hypertens       Date:  2012-12-21

8.  Arrhythmogenic Risk Assessment Following Four-Week Pretreatment With Nicotine and Black Tea in Rat.

Authors:  Siyavash Joukar; Vahid Sheibani; Faramarz Koushesh; Elham Ghasemipoor Afshar; Soodabe Ghorbani Shahrbabaki
Journal:  Res Cardiovasc Med       Date:  2015-08-01

9.  Clinical features and risk factor analysis for lower extremity deep venous thrombosis in Chinese neurosurgical patients.

Authors:  Fuyou Guo; Tagilapalli Shashikiran; Xi Chen; Lei Yang; Xianzhi Liu; Laijun Song
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

10.  Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events.

Authors:  Ole Frobert; Christian Reitan; Dorothy K Hatsukami; John Pernow; Elmir Omerovic; Pontus Andell
Journal:  Open Heart       Date:  2019-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.